The UK Minister of State for Science praised the UK’s thriving startup scene at the annual Jefferies London Healthcare ...

The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 million-dose donation by the Japanese ...

Tris Pharma has received additional ex-US approvals for its attention deficit hyperactivity disorder (ADHD) treatments, ...

The Phase III BROOKLYN trial saw HeFH patients randomly assigned in a 2:1 ratio to receive either obicetrapib or a placebo ...

The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for ...

Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scientific exchange between clinical experts and ...

Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in the seven major markets between 2023 and 2033 ...

Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab for malignant ascites.

UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare ...

Discover leading sales enablement and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to market forecasts and industry insights.

The US FDA has issued a CRL for sNDA of Astellas Pharma’s IZERVAY, a treatment for geographic atrophy (GA) secondary to AMD.

ReCode is set to secure up to $15m in funding from the Cystic Fibrosis Foundation to enhance its gene correction research ...